HPV16 Variants and Cervical Disease
Author Information
Author(s): Kämmer C, Tommasino M, Syrjänen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I
Hypothesis
Do polymorphisms in the long control region and E6 oncogene of HPV16 affect the oncogenic potential of the virus in northern European women?
Conclusion
The study found that E6 variants, particularly L83V, are associated with higher-grade cervical lesions, while LCR polymorphisms do not significantly influence disease progression.
Supporting Evidence
- Polymorphisms in the long control region were more frequent than in the E6 gene.
- The E6 variant L83V was enriched in high-grade lesions and cancer.
- Most LCR variants did not show a significant change in promoter activity.
Takeaway
This study looked at how different versions of a virus called HPV16 might affect whether women get cervical cancer. They found that one specific change in the virus is linked to more serious cases.
Methodology
The study sequenced the long control region and E6 gene of HPV16 from 45 samples and analyzed their promoter activity and correlation with disease status.
Participant Demographics
20 Swedish and 25 Finnish women, all HPV16-positive.
Statistical Information
P-Value
0.04
Statistical Significance
p=0.04
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website